M. Orlandi, M. Benaglia, L. Raimondi, G. Celentano
FULL PAPER
80 °C. [α]2D3 = –107.5 (c = 0.33 in CH2Cl2). 1H NMR (300 MHz,
CDCl3): δ = 9.10 (br. s, 1 H, NH), 7.87 (br. d, 2 H, Py-H), 7.65
(br. t, 1 H, Py-H), 4.25 (m, 2 H, CHN), 3.50 (m, 4 H, CH2N),
2.40–1.90 (m, 8 H, CH2CH2), 1.40 [s, 18 H, C(CH3)3] ppm. 13C
NMR (75 MHz, CDCl3): δ = 171.2, 158.6, 149.0, 140.5, 109.3, 80.8,
61.0, 47.1, 30.8, 29.4, 24.2 ppm.
for the first time as catalysts in Diels–Alder reactions be-
tween cyclopentadiene and cinnamaldehyde. A Michael re-
action was also successfully catalysed by the 2-imidazolyl-
derived prolinamide. Computational studies have been per-
formed to clarify the stereochemical behaviour of the cata-
lysts and to understand the role of the different structural
components of the chiral prolinamides in the interactions
between the catalyst and the reactants. The straightforward
synthesis of the new organocatalysts and a deep insight into
the transition-state structures of the reactions achieved by
PM6 calculations are further advantages of the reported
methodology. These studies represent a starting point for
the development of designed chiral compounds where mo-
lecular recognition processes between catalyst and reactants
may lead to the generation of supramolecular self-as-
sembled organocatalysts with new catalytic properties.
(S)-N-(6-Aminopyridin-2-yl)pyrrolidine-2-carboxamide (2a): White
solid, m.p. 55–59 °C. [α]2D3 = –35.5 (c = 0.27 in CH2Cl2). H NMR
1
(300 MHz, CDCl3): δ = 9.80 (br. s, 1 H, NH), 7.56 (d, 1 H, Py-H),
7.41 (t, 1 H, Py-H), 6.22 (d, 1 H, Py-H), 4.30 (br., 2 H, NH2), 3.85
(m, 1 H, CHN), 3.00 (m, 2 H, CH2N), 2.20–2.00 (m, 2 H,
CH2CH2), 1.95–1.85 (m, 2 H, CH2CH2) ppm. 13C NMR (75 MHz,
CDCl3): δ = 174.5, 157.0, 149.0, 140.7, 128.7, 104.1, 103.1, 67.5,
61.0, 47.2, 31.1, 24.3 ppm.
(2S,2ЈS)-2,2Ј-[Pyridine-2,6-diylbis(azanediyl)]bis(pyrrolidine-2-
carboxamide) (2b): White solid, m.p. 115–117 °C. [α]2D3 = –117.5 (c
1
= 0.11 in CH2Cl2). H NMR (300 MHz, CDCl3): δ = 9.70 (br. s, 1
H, NH), 7.66 (br. d, 2 H, Py-H), 7.55 (br. t, 1 H, Py-H), 3.95 (m,
2 H, CHN), 3.10 (m, 4 H, CH2N), 2.20–2.05 (m, 2 H, CH2CH2),
1.90–1.75 (m, 2 H, CH2CH2) ppm. 13C NMR (75 MHz, CDCl3): δ
= 170.5, 157.5, 149.0, 108.1, 68.5, 61.9, 49.2, 32.1 ppm.
Experimental Section
General Methods: TLC was performed on Merck silica gel 60 TLC
plates F254 and visualized using UV light or phosphomolybdic
acid. Flash chromatography was carried out on silica gel (230–
400 mesh). 1H NMR spectra were recorded at 300 MHz and 13C
NMR spectra were obtained at 75 MHz. Chemical shifts were cal-
ibrated using tetramethylsilane (for 1H) or residual solvent peaks
(for 13C). Optical rotations were obtained with a Perkin–Elmer 241
polarimeter at 589 nm. HPLC for ee determination was performed
with an Agilent 1100 instrument under the conditions reported be-
low. Semiempirical and DFT calculations were performed with
Gaussian09.[16–17] Frequency calculations allowed the characteriza-
tion of transition-state structures and the calculation of ZPE-cor-
rected free energies.
(S)-tert-Butyl 2-[6-(2,2,2-Trifluoroacetamido)pyridin-2-ylcarb-
1
amoyl]pyrrolidine-1-carboxylate (8): H NMR (300 MHz, CDCl3):
δ = 9.55 (br. s, 1 H, NH), 8.20 (br. s, 1 H, NH), 8.00 (d, 1 H, Py-
H), 7.86 (d, 1 H, Py-H), 7.75 (t, 1 H, Py-H), 4.45 (br. m, 1 H,
CHN), 3.48 (br. m, 2 H, CH2N), 2.27 (br. m, 2 H, CH2CH2), 1.96
(m, 2 H, CH2CH2), 1.47 [s, 9 H, C(CH3)3] ppm. 13C NMR
(75 MHz, CDCl3): δ = 170.79, 155.55, 154.54, 150.08, 147.11,
141.10, 111.45, 109.84, 81.18, 60.88, 47.29, 28.36, 24.44 ppm. 19F
NMR (282.1 MHz, CDCl3): δ = –77.75 ppm.
(S)-tert-Butyl 2-[6-(4-Methylphenylsulfonamido)pyridin-2-ylcarb-
1
amoyl]pyrrolidine-1-carboxylate (9): H NMR (300 MHz, CDCl3):
δ = 9.30 (br. s, 1 H, NH), 8.75 (br. s, 1 H, NH), 7.86 (br. d, 1 H,
Py-H), 7.73 (d, 2 H, Ph-H), 7.59 (br. t, 1 H, Py-H), 7.23 (d, 2 H,
Ph-H), 7.06 (br. d, 1 H, Py-H), 4.35 (br. m, 1 H, CHN), 3.50 (br.
m, 2 H, CH2N), 2.38 (s, 3 H, PhCH3), 2.16 (br. m, 2 H, CH2CH2),
2.16 (m, 2 H, CH2CH2), 1.91 [s, 9 H, C(CH3)3] ppm. 13C NMR
(75 MHz, CDCl3): δ = 171.72, 155.77, 154.22, 150.24, 148.78,
144.28, 140.90, 136.28, 129.77, 127.28, 109.67, 108.41, 80.62, 61.57,
47.11, 28.30, 24.35, 21.54 ppm.
Synthesis of Catalysts 2a and 2b, General Procedure: The synthesis
of catalyst 2a is reported as an example. 2,6-Diaminopyridine
(1.1 mmol) was added to a stirred mixture of (S)-Boc-proline
(1 mmol), EDC (3 mmol), and HOBt (hydroxybenzotriazole;
1 mmol) in DCM (3 mL) at room temperature. After 48 h, the mix-
ture was diluted with CH2Cl2 (7 mL), washed with HCl (3.7% aq.;
3ϫ 10 mL), and dried with Na2SO4. A concentrated solution ob-
tained under reduced pressure was purified by flash chromatog-
raphy on silica gel (hexane/ethyl acetate) to give the precursor of
2a, compound 7 (65%). To synthesise catalyst 2b, the condensation
of (S)-Boc-proline (2 equiv.) and 2,6-diaminopyridine (1 equiv.)
gave the precursor of 2b, compound 6 (61%), along with com-
pound 7 (27%). To obtain unprotected catalysts 2a or 2b, Boc de-
rivatives 6 or 7 were treated with a 1:1 TFA/CH2Cl2 solution for
30 min at room temp. Then CH2Cl2 was added to the reaction mix-
ture, the resulting solution was washed three times with NaHCO3
(sat. aq.), the organic extracts were dried, and the solvents were
evaporated under vacuum to give catalyst 2a or 2b (quantitative).
Synthesis of Catalyst 5: Oxalyl choride (4.8 mmol) was added to a
solution of Cbz-proline (1 g, 4 mmol) in CH2Cl2 under an inert
atmosphere. The reaction mixture was stirred at 40 °C for 4 h. After
this time, the solution of crude Cbz-proline chloride was concen-
trated under reduced pressure and the residue was dissolved in
DMF to give solution A. A mixture of 2-imidazolamine hydrogen
sulfate (2 mmol), DIPEA (16 mmol), and a catalytic amount of
DMAP (100 mg) in DMF was prepared (solution B). Solution A
was slowly added to solution B at 0 °C under a nitrogen atmo-
sphere. The resulting reaction mixture was allowed to warm to
room temp., and then it was stirred for 12 h. The reaction mixture
was concentrated under reduced pressure, and the residue was puri-
fied by flash chromatography on silica gel (CH2Cl2/MeOH) to give
Cbz-5 (30%).
(S)-tert-Butyl 2-(6-Aminopyridin-2-ylcarbamoyl)pyrrolidine-1-carb-
oxylate (7): Waxy solid. [α]2D3 = –67.5 (c = 0.23 in CH2Cl2). 1H
NMR (300 MHz, CDCl3): δ = 9.20 (br. s, 1 H, NH), 7.80 (br. d, 1
H, Py-H), 7.45 (br. t, 1 H, Py-H), 6.32 (br. d, 1 H, Py-H), 4.40 (br.,
2 H, NH2), 4.35 (m, 1 H, CHN), 3.50 (m, 2 H, CH2N), 2.20–1.90
(m, 4 H, CH2CH2), 1.38 [s, 9 H, C(CH3)3] ppm. 13C NMR
(75 MHz, CDCl3): δ = 170.5, 158.0, 151.0, 139.7, 128.4, 110.1,
108.7, 81.8, 61.2, 48.7, 30.7, 29.1, 24.0 ppm. HRMS (ESI+): calcd.
for C15H22N4O3Na [M + Na]+ 329.1590; found 329.15824.
Catalyst 5 was obtained in quantitative yield by hydrogenation of
Cbz-5 over Pd/C (10 %) in MeOH. Catalyst 5 was purified by
crystallization from chloroform before use.
(S)-Benzyl 2-[(1H-Imidazol-2-yl)carbamoyl]pyrrolidine-1-carboxyl-
ate (Cbz-5): White solid, [α]2D3 = –93.8 (c = 0.28 in CHCl3). 1H
(2S,2ЈS)-Di-tert-butyl
(carbonyl)}bis(pyrrolidine-1 carboxylate) (6): White solid, m.p. 77–
2,2Ј-{[Pyridine-2,6-diylbis(azanediyl)]bis- NMR (300 MHz, CDCl3): δ = 6.89 (s, 2 H, Im-H), 4.27 (br. m, 1
H, CHN), 3.38 (m, 2 H, CH2N), 2.41 (m, 1 H, CH2CH2), 2.16 (m,
2352
www.eurjoc.org
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2013, 2346–2354